MicroRNA-21: A promising biomarker for the prognosis and diagnosis of non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most common subtype of lung cancer worldwide. The high mortality rate of NSCLC is due to a limited number of diagnosis being made at an early stage of disease. Therefore, the development of a novel biological marker for the diagnosis and prognosis prediction...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Zheng, Wen, Zhao, Juanjuan, Tao, Yijing, Guo, Mengmeng, Ya, Zhou, Chen, Chao, Qin, Nalin, Zheng, Jing, Luo, Junmin, Xu, Lin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2018
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6096285/
https://ncbi.nlm.nih.gov/pubmed/30127862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8972
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller